mirogabalin
Sign in to saveAlso known as DS-5565, Tarlige
Mirogabalin (brand name Tarlige; developmental code name DS-5565) is a gabapentinoid medication developed by Daiichi Sankyo. Gabapentin and pregabalin are also members of this class. As a gabapentinoid, mirogabalin binds to the α2δ subunit of voltage-gated calcium channel (1 and 2), but with significantly higher potency than pregabalin. It has shown promising results in Phase II clinical trials for the treatment of diabetic peripheral neuropathic pain.
Wikidata facts
- Mass
- 209.141578848
Show 4 more facts
- canonical SMILES
- CCC1=CC2C(C1)CC2(CN)CC(=O)O
- isomeric SMILES
- CCC1=C[C@@H]2[C@H](C1)C[C@@]2(CC(=O)O)CN
- chemical formula
- C₁₂H₁₉NO₂
- Commons category
- Mirogabalin
Sources (2)
via Wikidata · CC0
~1 min read
Article
2 sectionsContents
- References
- External links
Mirogabalin (brand name Tarlige; developmental code name DS-5565) is a gabapentinoid medication developed by Daiichi Sankyo. Gabapentin and pregabalin are also members of this class. As a gabapentinoid, mirogabalin binds to the α2δ subunit of voltage-gated calcium channel (1 and 2), but with significantly higher potency than pregabalin. It has shown promising results in Phase II clinical trials for the treatment of diabetic peripheral neuropathic pain.
Phase III trial results: Effective: for post-herpetic neuralgia (trial: NEUCOURSE) Ineffective: for fibromyalgia (trial: ALDAY) Effective: for diabetic peripheral neuropathic pain (trial: REDUCER)